⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANVS News
Annovis Bio, Inc.
Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026
globenewswire.com
ANVS
Annovis to Attend the CTAD 2026 with Three Presentations
globenewswire.com
ANVS
Form 8-K
sec.gov
ANVS
Parkinson's Disease Market Poised for Expansion During the Forecast Period (2026-2036) Amid JUVMO Approval and Emerging Therapeutic Innovations | DelveInsight
prnewswire.com
ABBV
ANVS
ACIU
BHF
MGNX
NBIX
UCB
Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer’s Disease
globenewswire.com
ANVS
ROTH to Host 5th Annual Healthcare Opportunities Conference on September 29 in New York City
globenewswire.com
ANVS
CRVO
MGNX
MNOV
Major Depressive Disorder Clinical Trial Pipeline Boom as 75+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
AXSM
VRTX
RLMD
VSTA
PRAX
NBIX
ALTO
LLY
JNJ
MRK
ABBV
BMY
REGN
BIIB
ANVS
ALEC
LEXX
COYA
NVO
IONQ
NVDA
AMD
INTC
GOOG
MSFT
AMZN
TSLA
AAPL
META
IBM
CRM
ADBE
NFLX
CMCSA
VZ
T
KO
PEP
MCD
DIS
BA
CAT
GE
XOM
CVX
JPM
BAC
WFC
GS
MS
V
MA
HD
WMT
COST
PG
PFE
MRNA
GILD
AMGN
NVS
TAK
EXAS
CRSP
EDIT
NTLA
INCY
ALKS
ACAD
AZN
TEVA
BHC
LULU
UBER
LYFT
SPCE
PLTR
SNOW
DDOG
CRWD
ZS
PANW
FTNT
NOW
ADSK
MCHP
NXPI
ON
QCOM
MU
WDC
SE
MELI
BABA
JD
PDD
NTES
BIDU
IQ
VIPS
NIO
XPEV
LI
RIVN
LCID
PLUG
FCEL
BE
SPWR
ENPH
SEDG
RUN
NEO
CLSK
CRBU
RXRX
DTIL
ADPT
CYTK
IMUX
MNKD
SRPT
BNTX
RVMD
ACRS
EXEL
FGEN
GNTX
HRMY
INSM
ITRM
KODK
LPCN
NCLH
OCGN
ORGO
PACB
PBYI
PEGA
PLRX
PRGS
PTON
PYPL
QGEN
QRVO
RDNT
REPL
ROKU
RYAAY
SAVA
SBAC
SCLX
SDRL
SEIC
SIRI
SMCI
SNPS
SOFI
SPOT
SSYS
STX
SWKS
SYK
TCOM
TEAM
TER
TGT
TMO
TMUS
TXN
UAL
ULTA
UPS
VRSK
WDAY
XEL
XYL
ZBRA
Multiple System Atrophy Clinical Trial Pipeline Gains Momentum: 22+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
ASMB
IONS
BIIB
ALT
TEVA
ANVS
SUPN
ABBV
AVXL
MRK
KAR
VNDA
Annovis to Host Corporate Update Webinar on September 2, 2026
globenewswire.com
ANVS
Form 8-K
sec.gov
ANVS